DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rallied 2.02% to $191.82 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.43% to 6,878.88 and Dow Jones Industrial Average falling 1.05% to 48,977.92.
The stock's rise snapped a three-day losing streak.
Biogen Inc. closed 5.23% below its 52-week high of $202.41, which the company reached on February 6th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 2.04% to $248.43, Pfizer Inc. $(PFE)$ rose 2.03% to $27.65, and AbbVie Inc. $(ABBV)$ rose 3.29% to $232.08.
Trading volume (1.4 M) remained 386,337 below its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 27, 2026 17:02 ET (22:02 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments